Lesson’s Learned from Building out the Commercial Organization

SK Life Science breaks through Covid barriers to bring epilepsy drug to market

Lutronic’s Focus on Change during the Pandemic

From Big Pharma to Startup: What are the Challenges?

The View from Olympus: How This MedTech Leader Approached the Pandemic

DENTALEZ COO Heather Trombley on Reinvigorating the Company

Seqirus Exec on Vaccine Differentiation

Zimmer Biomet VP on Covering the Territory

How Teleflex Grew its Market Value 4x in 6 Years

Admedus COO David St. Denis on Courage, Commitment and Conversation

1 min read

AbbVie to Acquire Nimble Therapeutics for $200M, Expanding Autoimmune Pipeline and Peptide Innovation Platform

North Chicago, IL and Madison, WI, December 13, 2024 (PRNewswire) -- AbbVie will acquire Nimble Therapeutics, gaining its lead oral peptide IL23R inhibitor for psoriasis, a pipeline of autoimmune candidates, and a proprietary peptide optimization platform. The deal highlights AbbVie’s strategic focus on innovative therapies. This acquisition strengthens its capabilities in peptide-based drug discovery and autoimmune treatment development.

Read full article here.

Recent Posts

See All

Capstan Medical Secures $110M in Series C Funding to Advance Robotic Heart Valve Implants

Santa Cruz, CA, December 13, 2024 (Yahoo) -- Capstan Medical has raised $110 million in a Series C funding round led by Eclipse, with...

Franklin Biolabs Appoints Dr. Vatsala Naageshwaran as CEO to Lead Genetic Medicines Innovation

Philadelphia, December 4, 2024 (PRNewswire) -- Dr. Vatsala Naageshwaran, an accomplished biopharmaceutical leader, has been appointed...

SiteOne Therapeutics Secures $100M in Series C Financing to Advance Non-Opioid Pain Treatments

South San Francisco, CA, December 18, 2024 (Business Wire) -- SiteOne Therapeutics has raised $100 million in Series C funding to...

Capstan Medical Secures $110M in Series C Funding to Advance Robotic Heart Valve Implants

Franklin Biolabs Appoints Dr. Vatsala Naageshwaran as CEO to Lead Genetic Medicines Innovation

SiteOne Therapeutics Secures $100M in Series C Financing to Advance Non-Opioid Pain Treatments

Pleno Appoints Dr. Vik Vaz as CEO to Lead Commercial Growth

AbbVie to Acquire Nimble Therapeutics for $200M, Expanding Autoimmune Pipeline and Peptide Innovation Platform

Coherus Divests UDENYCA Franchise to Intas in $558.4M Deal to Fund Immuno-Oncology Expansion

COUR Pharmaceuticals Secures $40M Upfront in Genentech Deal, Potential Milestones Exceed $900M

BioFuse Medical Technologies Appoints Rick Early as CEO

Velentium Appoints Matt Hanks as CEO, Co-Founder Dan Purvis Named Board Chair to Propel Growth

Novartis Bets $2.9B on PTC Therapeutics' Huntington’s Disease Drug Breakthrough

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...

Executive Spotlights

AbbVie to Acquire Nimble Therapeutics for $200M, Expanding Autoimmune Pipeline and Peptide Innovation Platform

Recent Posts

Life Science Headlines